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Abstract 
Fontan fenestration closure is a topic of great debate. The body of data regarding the risks and benefits of 
fenestration closure is limited yet growing. Previous studies have demonstrated that Fontan patients have less 
exercise capacity than those with normal cardiovascular anatomy. Differences also have been noted within 
various subgroups of Fontan patients such as whether Fontan is fenestrated or not. This study aimed to compare 
trends in regional oxygen saturations using near-infrared spectroscopy (NIRS) in patients with Fontan 
circulations during ramping exercise to further delineate differences between patients with and without a 
fenestration. It was hypothesized that Fontan patients with fenestrations have better exercise times, higher 
absolute regional oxygen venous saturations, and smaller arteriovenous differences than Fontan patients 
without fenestrations. For this study, 50 consecutive Fontan patients and 51 consecutive patients with normal 
cardiovascular anatomy were recruited. Placement of NIRS probes was performed to obtain regional oxygen 
saturations from the brain and the kidney. Readings were obtained at 1-min intervals during rest, exercise, and 
recovery. A standard Bruce protocol was used with a 5-min recovery period. Absolute regional tissue 
oxygenation values (rSO2) and arterial-venous oxygen saturation differences (AVDO2) calculated as arterial 
oxygen saturation (SPO2)—rSO2 for normal versus Fontan patients and for fenestrated versus unfenestrated 
Fontan patients were compared using independent t tests. When normal and Fontan patients were compared, 
the Fontan patients had a significantly shorter duration of exercise (9.3 vs 13.2 min; p < 0.001). No statistically 
significant difference in rSO2 change or AVDO2 was evident at the time of peak exercise, at 2 min into the 
recovery, or at 5 min into the recovery. A small oxygen debt also was paid back to the brain in the Fontan 
patients after exercise, as evidenced by a narrower AVDO2 than at baseline. The comparison of Fontan patients 
with and without fenestration showed no statistically significant difference in exercise time, rSO2 change, or 
AVDO2. The Fontan patients were noted to have shorter exercise times than the normal patients and also 
appeared to have an alteration in postexertional regional blood flow. However, when the various Fontan 
subtypes were compared by presence or absence of a fenestration, no significant differences were noted with 
regard to change in regional oxygen saturation or arteriovenous oxygen saturation. Thus, for patients with 
Fontan physiology, closure of the fenestration does not seem to have an impact on the dynamics of regional 
oxygen extraction during exercise or recovery. 
Introduction 
Findings have well documented that the Fontan procedure used as palliation for patients with a single ventricle 
leads to a reduction in exercise capacity. This manifests itself through a significant reduction in exercise time, 
peak oxygen consumption (peak VO2), and exercise intensity [5, 8, 10, 11, 13, 14, 16, 18, 22, 26, 32, 35, 36, 38]. 
This impairment in exercise capacity results from the interaction of many different factors, which include, but 
are not limited to, the following: a dramatic increase in pulmonary artery systolic pressure with subsequent 
reduction in ventricular stroke volume, a decrease in ventricular end-diastolic pressure, inadequate ventricular 
preoload reserve, impairment of the autoregulation of systemic vascular resistance, and the absence of a 
prepulmonary pump [2, 4, 12, 20, 21, 27, 33, 34]. Exercise capacity is of particular importance in Fontan patients 
because it affects quality of life in this physiologically unique population. 
During the years since the initial reports of the Fontan operation, this palliative procedure has undergone many 
modifications and has seen new applications. One such modification has been the introduction of a fenestration. 
The short-term benefits of fenestration include a shorter postoperative hospital stay, decreased chest tube 
drainage, and a decreased need for mechanical ventilation [1, 6, 7]. However, the long-term effects of 
fenestration are unclear. 
The potential benefits of fenestration beyond the early postoperative period include reduction of protein-losing 
enteropathy, plastic bronchitis, and dysrhythmias. The potential risks of fenestration include cyanosis and 
thromboembolism. The current data on the impact of fenestration on exercise capacity is similarly conflicting, 
with no obvious answer as to whether a benefit exists or not [24, 25]. 
Previous studies have demonstrated regional tissue oxygenation (rSO2) trends in Fontan patients using near-
infrared spectroscopy (NIRS) during cardiopulmonary exercise testing (CPET) [9, 30, 31]. The NIRS techniques use 
the Beer–Lambert law in measuring the concentration of a substance using its absorption of light [29]. The NIRS 
procedure allows for a noninvasive, continuous means of monitoring rSO2 by detecting venous-weighted 
oxyhemoglobin saturation in real time. 
This study aimed to investigate further the effect of fenestration status on exercise capacity using rSO2 while 
also characterizing NIRS trends in exercising Fontan patients with varying fenestration statuses. 
Methods 
This study was initiated with funding assistance from the Children’s Research Institute, a division of Children’s 
Hospital and Health System, and the Medical College of Wisconsin, Milwaukee, Wisconsin. It received approval 
from the Institutional Review Board. All patients who had undergone a previous Fontan procedure were eligible 
for inclusion in the study if they had been referred to undergo CPET by a cardiologist at the Herma Heart 
Center’s Exercise Physiology Laboratory for further evaluation of symptoms or function. Patients with no 
structural heart disease or acquired heart disease who had been referred for CPET also were eligible for 
inclusion and formed the control group. 
The single-ventricle patients included in the study all had undergone a three-stage approach for palliation 
consisting of a Norwood procedure, Glenn anastomosis, and completion Fontan. All the patients underwent a 
routine clinical evaluation consisting of a thorough history and physical examination before CPET. Consent and 
assent from the parents were obtained before enrollment of any patients in the study. All patients were tested 
during an outpatient visit, and no activity restrictions were given before testing. 
Preexercise Testing 
The CPET protocol began with application of 12-lead electrocardiogram leads, an automated oscillometric blood 
pressure cuff on the left arm, and a pulse oximeter on the right index finger to measure arterial oxygen 
saturation (SpO2) (GE-Marquette, Waukesha, WI, USA). Four NIRS probes with 4-cm source-detector spacing and 
shallow-field rejection (Adult Somasensor, Covidien 5100C; Somanetics Corp, Troy, MI, USA) were placed on the 
forehead midline (rSO2 C), below the 12th rib in the left paravertebral space (rSO2 R), on the vastus lateralis 
(rSO2 L), and on the deltoid muscle (rSO2 A), respectively. Resting echocardiography (Siemens; Acuson, Mountain 
View, CA, USA) and electrocardiography (GE Medical Systems; Milwaukee, WI, USA) were performed before 
CPET. 
Four-site regional rSO2 and SpO2 were measured and recorded continuously at 6-s intervals during rest, exercise, 
and a 5-min recovery period. Baseline spirometry (Care Fusion, Yorba Linda, CA, USA) was performed using a 
forced expiratory maneuver according to the standards of the American Thoracic Society. Forced vital capacity 
(FVC), forced expiratory volume in 1 s (FEV1), peak expiratory flow (PEF), and maximal mid-expiratory flow were 
collected. Measurements of breath-by-breath oxygen consumption (VO2), carbon dioxide production (VCO2), 
and instantaneous respiratory quotient (RQ) also were obtained. 
Exercise Testing 
Patients were oriented to the treadmill and given specific instructions about what to expect during the exercise 
portion of the study. After 1 min of baseline data collection, a modified Bruce protocol was initiated. The 
workload was progressively increased at set intervals throughout the test until the patient reached voluntary or 
symptom-limited exhaustion (quitting time [QT]). 
Electrocardiography, blood pressure, oxygen saturation, and breath-by-breath ventilatory data were recorded at 
1-min intervals throughout the exercise portion of the test. Immediately after the exercise portion of the test 
was a 5-min recovery period (3 min of walking followed by a 2 min of sitting). All SpO2, heart rate, blood 
pressure, VO2, VCO2, RQ, and NIRS data were synchronously aggregated. Patients unable to complete the CPET 
protocol and those who had incomplete metabolic chart data acquisition were excluded from the study. 
Data Analysis 
Means and standard deviations were calculated for all baseline characteristics and then compared between the 
control and Fontan patients and between the fenestrated and unfenestrated Fontan patients using 
unpaired t tests. The mean percentage of change in rSO2 and rterial-venous oxygen saturation differences 
(AVDO2) from baseline to the following time points was calculated and plotted: peak exercise, 2 min after 
exercise, and 5 min after exercise. The mean change at these time points for the normal and Fontan groups then 
was compared using the unpaired t test. Statistical analysis was performed using SPSS statistical software, 
version 20.0 (SPSS, Chicago, IL, USA). All p values lower than 0.05 were considered statistically significant. 
Results 
Normal Versus Fontan Patients 
The study enrolled 51 normal patients and 50 Fontan patients. Comparisons of the baseline characteristics 
between these two groups are summarized in Table 1. As expected, the Fontan patients tended to be younger 
and to have lower weight (in pounds), FVC, FEV1, resting systolic blood pressure, and resting diastolic blood 
pressure. The Fontan patients also tended to have significantly lower resting renal oxygen saturations 
(65.4 ± 10.8 vs 76.8 ± 9.3 %; p < 0.001) and lower cerebral oxygen saturations (60.7 ± 8.8 vs 
69.9 ± 10.1 %; p < 0.001). When this relationship was further examined in terms of Fontan fenestration status, 
the unfenestrated Fontan patients had a lower mean resting cerebral saturation (63.1 ± 8.6 %) than the normal 
patients (p = 0.002) as well as a lower mean resting renal saturation (66.8 ± 11.0 %; p < 0.001). 
Table 1 Comparison of baseline characteristics between normal and Fontan patients  
Normal Fontan p Value 
No. of patients 51 50   
No. of males: n (%) 26 (52) 33 (66)   
Age (years) 16.6 ± 6.7 11.6 ± 3.8 <0.001 
Weight (lb) 132.8 ± 34.2 79.4 ± 28.5 <0.001 
Height (in.) 65.9 ± 4.9 59.8 ± 17.1 0.012 
FVC (L) 3.8 ± 1.0 1.9 ± 0.8 <0.001 
FEV1 (L) 3.4 ± 0.9 1.6 ± 0.6 <0.001 
PEF (L/min) 6.8 ± 1.7 7.3 ± 13.5 0.895 
Resting respiratory rate (rpm) 49.7 ± 11.6 51.0 ± 12.3 0.626 
Resting heart rate (bpm) 74.5 ± 12.5 83.3 ± 16.8 <0.001 
Resting systolic blood pressure (mmHg) 110.7 ± 8.5 100.5 ± 11.1 <0.001 
Resting diastolic blood pressure (mmHg) 68.0 ± 8.3 60.2 ± 8.3 <0.001 
Resting systemic saturation (%) 95.0 ± 1.0 93.1 ± 4.1 0.002 
Resting renal saturation (%) 76.8 ± 9.3 65.4 ± 10.8 <0.001 
Resting cerebral saturation (%) 69.9 ± 10.1 60.7 ± 8.8 <0.001 
Resting deltoid saturation (%) 76.8 ± 9.0 70.4 ± 7.6   
Resting vastus lateralis saturation (%) 62.9 ± 11.1 56.6 ± 8.2 0.009 
Exercise time (min) 13.2 ± 2.5 9.3 ± 1.8 <0.001 
VO2 at peak exercise 2.6 ± 0.9 1.4 ± 0.5 0.254 
End-tidal CO2 at peak exercise 37.7 ± 5.0 31.5 ± 4.9 0.283 
RQ at peak exercise 1.1 ± 0.1 1.0 ± 0.9 0.675 
FVC forced vital capacity, FEV 1 forced expiratory volume in 1 s, PEF peak expiratory 
flow, rpm revolutions/min, bpm beats/min, VO 2 oxygen consumption, CO 2 carbon dioxide, RQ respiratory 
quotient 
The fenestrated Fontan patients had a lower mean resting cerebral oxygen saturation (55.7 ± 7.3 %; p < 0.001) 
than the normal patients and a lower mean resting renal oxygen saturation (58.3 ± 18.5 %; p < 0.001). Exercise 
time in minutes also was significantly shorter among the Fontan patients than among the normal patients 
(9.3 ± 1.8 % vs 13.2 ± 2.5 %; p < 0.001). 
Regional renal oxygen saturations showed a greater change from baseline in the Fontan patients than in the 
normal patients (−4.1 vs −0.6 %) 2 min into the recovery period. Otherwise, renal rSO2 did not differ significantly 
at peak exercise or 5 min into recovery. The change in cerebral rSO2 from baseline to any time point did not 
differ significantly between the Fontan and normal patients (Table 2). Neither did the renal or cerebral 
AVDO2 differ significantly at the predefined time points between the Fontan and normal patients. A morphologic 
right ventricle was found in 27 of the Fontan patients and a morphologic left ventricle in the remaining patients. 
Table 2 Change in regional venous oxygen saturations between normal and Fontan patients at predefined 
timesa 
  Change from rest to 
peak exercise 
Change from rest to 2 min 
into recovery 
Change from rest to 5 min 
into recovery 
Kidney: normal −18.5 (−24.1) −0.5 (−0.6)b 1.4 (1.8) 
Kidney: Fontan −14.9 (−22.8) −2.7 (−4.1) −0.3 (−0.4) 
Brain: normal −5.5 (−7.6)b 0.1 (0.1) 3.9 (5.6) 
Brain: Fontan −7.0 (−11.5) 0.7 (1.2) 4.1 (6.7) 
Deltoid: normal 20.2 (−26.3) 2.8 (−3.7) 1.5 (2.0) 
Deltoid: Fontan −14.5 (−20.6) −4.6 (−6.6) −0.9 (−1.3) 
Vastus lateralis: 
normal 
−8.3 (−13.2) 8.7 (13.8)b 9.8 (15.6) 
Vastus lateralis: 
Fontan 
−6.0 (−10.6) 3.6 (6.3) 4.6 (8.1) 
aValues are expressed as absolute change (% change) 
bSignificant difference in rSO2 between the NL and Fontan groups at any given time interval 
 
Fenestrated Versus Unfenestrated Fontan 
Of the 50 Fontan patients, 16 were fenestrated and 34 were unfenestrated. The baseline characteristics of these 
two groups demonstrated significantly lower age, weight, and height in the fenestrated Fontan group (Table 3). 
The baseline FVC, FEV1, resting systolic blood pressure, and resting diastolic blood pressure also were 
significantly lower in this group. The resting systemic oxygen saturations were significantly lower in the 
fenestrated Fontan patients, with an average saturation of 89.3 % compared with 94.9 % in the unfenestrated 
Fontan patients (p < 0.001). The resting cerebral venous oxygen saturations also were lower in the fenestrated 
Fontan patients, with an average saturation of 55.7 % compared with 63.1 % in the unfenestrated Fontan 
patients (p < 0.003). The exercise times did not differ significantly between the two groups, with the fenestrated 
Fontan patients averaging 8.7 min compared with 9.6 min among the unfenestrated Fontan patients. 
Table 3 Comparison of baseline characteristics between Fontan patients with and without fenestration  
Fenestrated Unfenestrated p value 
No. of patients 16 34   
No. of males: n (%) 9 (56) 24 (71)   
Age (years) 8.8 ± 2.1 12.9 ± 4.3 <0.001 
Weight (lb) 57.7 ± 14.3 89.0 ± 28.3 <0.001 
Height (in.) 50.3 ± 5.5 64.1 ± 19.0 <0.001 
FVC (L) 1.3 ± 0.2 2.3 ± 0.8 0.002 
FEV1 (L) 1.2 ± 02 1.9 ± 0.6 0.006 
PEF (L/min) 3.2 ± 0.9 4.5 ± 19.1 0.110 
Resting respiratory rate (rpm) 59.1 ± 9.7 48.9 ± 12.3 0.049 
Resting heart rate (bpm) 86.4 ± 18.5 81.9 ± 16.1 0.422 
Resting systolic blood pressure (mmHg) 93.8 ± 8.3 103.7 ± 1.1.1 0.001 
Resting diastolic blood pressure (mmHg) 53.5 ± 6.8 63.4 ± 7.1 <0.001 
Resting systemic saturation (%) 89.3 ± 4.1 94.9 ± 2.8 <0.001 
Resting renal saturation (%) 62.2 ± 10.4 66.8 ± 11.0 0.172 
Resting cerebral saturation (%) 55.7 ± 7.3 63.1 ± 8.6 0.003 
Resting deltoid saturation (%) 65.6 ± 5.7 72.4 ± 7.9 0.075 
Resting vastus lateralis saturation (%) 56.8 ± 9.6 56.5 ± 8.4 0.954 
Exercise time (min) 8.7 ± 1.6 9.6 ± 1.8 0.089 
VO2 at peak exercise 0.9 ± 0.2 1.5 ± 0.4 0.438 
End-tidal CO2 at peak exercise 28.9 ± 3.9 32.2 ± 4.9 0.284 
RQ at peak exercise 0.9 ± 0.1 1.0 ± 0.1 0.734 
FVC forced vital capacity, FEV 1 forced expiratory volume in 1 s, PEF peak expiratory 
flow, rpm revolutions/min, bpm beats/min, VO 2 oxygen consumption, CO 2 carbon dioxide, RQ respiratory 
quotient 
The change in renal and cerebral rSO2 from baseline to predefined time points is depicted in Table 4. This change 
from baseline to any of the predefined time points did not differ between the Fontan patients based on 
fenestration status. The only exception to this was observed 5 min into the recovery, at which point the 
unfenestrated Fontan patients had a 1.2-point increase in renal venous oxygen saturation from resting values 
compared with a 5.9-point decrease in the fenestrated group. Table 3 compares the average renal and cerebral 
rSO2 trends during CPET between the fenestrated and unfenestrated Fontan patients. The AVDO2 did not differ 
between these two groups at any of the predefined time points. 
Table 4 Change in regional venous saturations between Fontan patients with and without fenestration at 
predefined times 
  Change from rest 
to peak 
Change from rest to 2 min 
into recovery 
Change from rest to 5 min 
into recovery 
Kidney: fenestrated −14.4 (−23.1) −0.4 (−5.9) −3.7 (−5.9)b 
Kidney: unfenestrated −14.7 (−22.0) −2.3 (−3.5) 0.8 (1.2) 
Brain: fenestrated −5.1 (−9.1) 1.2 (2.1) 4.5 (8.1) 
Brain: unfenestrated −7.6 (−12.1) 0.4 (0.7) 3.8 (6.1) 
Deltoid: fenestrated −3.2 (−4.9)b −3.4 (−5.2) −3.8 (–5.8) 
Deltoid: unfenestrated −16.4 (−22.6) −5.2 (−7.2) 0.7 (1.0) 
Vastus lateralis: 
fenestrated 
−2.0 (−3.5) 0.7 (1.2) 0.1 (0.2)b 
Vastus lateralis: 
unfenestrated 
−5.3 (−9.3) 4.4 (7.7) 6.8 (12.02) 
aValues are expressed as absolute change (% change) 
bSignificant difference in rSO2 between the fenestrated and unfenestrated groups at any given interval 
 
In terms of peak VO2, the Fontan patients with fenestration had a mean of 33.0 mL/kg/min compared with 
Fontan patients without fenestration, who had a mean of 34.6 mL/kg/min. When these are converted into 
percentage of predicted values, the Fontan patients with fenestration had a mean of 72.1 ± 7.5 % compared 
with a mean of 72.3 ± 13.3 % for the Fontan patients without fenestration. Neither of these comparisons 
demonstrated any statistical difference, with p values of 0.633 and 0.977, respectively. 
Discussion 
This study is the first to report the use of NIRS during CPET in Fontan patients. The findings demonstrate no 
significant effect of fenestration status on regional venous oxygen saturations during exercise in Fontan patients 
in different visceral beds with differing flow metabolism control mechanisms. Changes in cerebral, renal, and 
skeletal muscle NIRS values from baseline to various points in CPET did not differ significantly between the two 
groups except for minor differences noted at the 5-min recovery time point in cerebral venous oxygen 
saturations. The AVD02 also did not differ between the two groups, demonstrating that distribution of blood 
flow and oxygen extraction during exercise may be unaffected by fenestration status. These trends were noted 
despite the lower absolute regional oxygen saturations noted in the fenestrated group, a phenomenon expected 
because of the right-to-left shunt provided by the fenestration. 
Together with similar NIRS trends, both the Fontan patients with and without fenestration also had similar 
exercise times in this cohort. This, however, may simply represent the findings for a relatively younger Fontan 
population. Previous studies have documented that Fontan patients in late adolescence tend to have the 
greatest decrease in exercise capacity, so it still is possible that fenestration status has effects on exercise time 
that are statistically significant as Fontan patients age [15, 17]. Exercise times in Fontan patients have not been 
reported previously with respect to fenestration status specifically. 
Regarding ventilatory capacity, this study found no difference in absolute peak VO2 or percentage of predicted 
peak VO2 between the Fontan patients with and without fenestration. This indicates that exercise capacity may 
not differ between Fontan patients based on fenestration status. This finding is consistent with the findings of 
an earlier study by Meadows et al. [24], which demonstrated no improvement in peak VO2 in patients before 
and after fenestration closure. The study by Meadows et al. [24], however, did find improvements in the 
VE/VCO2 slope, end-tidal CO2 at the anaerobic threshold, and end-tidal O2 at peak exercise. 
An additional finding of note was the greater AVD02 observed in the Fontan patients than in the normal patients. 
Although this was not surprising in and of itself, the fact that this occurred even when fenestrated and 
unfenestrated Fontan patients were compared with normal patients separately is surprising. This may have been 
due in part to a limitation in cerebral blood flow resulting from the lack of a subpulmonary ventricle and from 
the subsequent low systemic venous compliance. An exaggerated hyperventilatory response in Fontan patients 
during exercise also may contribute to this [30]. 
Data on significant differences between Fontan patients with and without fenestration can help to determine 
whether fenestration closure is necessary or not. Currently, no guidelines on fenestration closure exist, and the 
decision often is based on physician preference and limited anecdotal evidence. Whether a fenestration offers a 
benefit in the long term or not still remains to be well delineated. 
A study by Ono et al. [28] demonstrated that those with a fenestration had statistically significantly longer 
survival and freedom from tachyarrhythmia 10 years after the Fontan procedure than those without a 
fenestration. Freedom from reoperation at 10 years also was greater, although this difference did not reach 
statistical significance. 
The benefits of a fenestration in reducing the incidence of protein-losing enteropathy also have been 
demonstrated. One such study evaluated patients who underwent transcatheter Fontan fenestration for 
protein-losing enteropathy after a median of 11.3 years, with limited success in preventing future recurrences. 
Many of the recurrences reported occurred years after the fenestration, a point at which the fenestration may 
have spontaneously closed. Thus, a patent fenestration may have provided some benefit for these patients even 
long after the Fontan procedure [37]. 
The benefits of fenestration closure also have been documented. In addition to improvement in arterial oxygen 
saturations, improvements in aerobic capacity also have been noted [23]. 
Another series followed patients for 10 years after the Fontan procedure and noted improvement in 
oxygenation, reduction in the need for cardiac medications, and improvement in somatic growth. It also has 
been hypothesized that fenestration closure may reduce the risk for thromboembolic events, although this has 
not been substantiated by studies [3, 19]. 
The limitations of this study included susceptibility to bias due to its retrospective nature. Fenestrations are 
more common in the more recent surgical era, and this may be reason why those with fenestration had a lower 
baseline age. 
Another limitation of this study was that the patients with and without fenestrations represented two distinct 
populations and not a single population before and after fenestration closure. Small sample size and no prior 
similar data comparing Fontan patients with and without fenestration also were limiting factors. The difference 
in baseline ages between the groups also was a limitation of this study. 
Conclusion 
This study demonstrated that blood flow distribution, regional oxygen extraction, and exercise time did not 
differ between the Fontan patients with and without fenestration during rest or exercise. A paucity of data still 
remains with regard to the long-term risks and benefits of fenestration, although this study has added to the 
data demonstrating that routine fenestration closure is necessary. 
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